Dataset Information

Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.

ABSTRACT:

Objective

To determine the acceptance rate of treatment alternatives for women with either preinvasive conditions or gynecologic cancers during the COVID-19 pandemic among Latin American gynecological cancer specialists.

Methods

Twelve experts in gynecological cancer designed an electronic survey, according to recommendations from international societies, using an online platform. The survey included 22 questions on five topics: consultation care, preinvasive cervical pathology, and cervical, ovarian, and endometrial cancer. The questionnaire was distributed to 1052 specialists in 14 Latin American countries. A descriptive analysis was carried out using statistical software.

Results

A total of 610 responses were received, for an overall response rate of 58.0%. Respondents favored offering teleconsultation as triage for post-cancer treatment follow-up (94.6%), neoadjuvant chemotherapy in advanced stage epithelial ovarian cancer (95.6%), and total hysterectomy with bilateral salpingo-oophorectomy and defining adjuvant treatment with histopathological features in early stage endometrial cancer (85.4%). Other questions showed agreement rates of over 64%, except for review of pathology results in person and use of upfront concurrent chemoradiation for early stage cervical cancer (disagreement 56.4% and 58.9%, respectively).

Conclusion

Latin American specialists accepted some alternative management strategies for gynecological cancer care during the COVID-19 pandemic, which may reflect the region's particularities. The COVID-19 pandemic led Latin American specialists to accept alternative management strategies for gynecological cancer care, especially regarding surgical decisions.

SUBMITTER: Rodriguez J

PROVIDER: S-EPMC9087623 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.

Rodriguez Juliana J Fletcher Angélica A Heredia Fernando F Fernandez Robinson R Ramírez Salazar Heidy H Sanabria Daniel D Burbano Luna Javier J Guerrero Eduardo E Pierre Marc-Edy ME Rendón Gabriel J GJ Rosero Indira I Trujillo Lina María LM Ribeiro Reitan R Baiocchi Glauco G Lopez Blanco Aldo A Malca Magaly M Hoegl Jorge J Borges Garnica Alfredo A Lasso de la Vega Jorge J Scasso Santiago S Laufer Joel J Estrada Erick Estuarto EE Gutierrez Criado Armando A Herbert Nuñez Guillermo Sidney GS Cantú-de Leon David D Medina Gonzalo G Pendola Gómez Luis L Saadi José J Noll Florencia F Arévalo Sandoval Danilo D Ferreira Oliveira Alexandre A Pareja Rene R

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20200717 3

<h4>Objective</h4>To determine the acceptance rate of treatment alternatives for women with either preinvasive conditions or gynecologic cancers during the COVID-19 pandemic among Latin American gynecological cancer specialists.<h4>Methods</h4>Twelve experts in gynecological cancer designed an electronic survey, according to recommendations from international societies, using an online platform. The survey included 22 questions on five topics: consultation care, preinvasive cervical pathology, a ...[more]

PMID: 32526044

Similar Datasets

Project description:BackgroundThe COVID-19 outbreak has resulted in collision between patients infected with SARS-CoV-2 and those with cancer on different fronts. Patients with cancer have been impacted by deferral, modification, and even cessation of therapy. Adaptive measures to minimize hospital exposure, following the precautionary principle, have been proposed for cancer care during COVID-19 era. We present here a consensus on prioritizing recommendations across the continuum of sarcoma patient care.Material and methodsA total of 125 recommendations were proposed in soft-tissue, bone, and visceral sarcoma care. Recommendations were assigned as higher or lower priority if they cannot or can be postponed at least 2-3 months, respectively. The consensus level for each recommendation was classified as "strongly recommended" (SR) if more than 90% of experts agreed, "recommended" (R) if 75%-90% of experts agreed and "no consensus" (NC) if fewer than 75% agreed. Sarcoma experts from 11 countries within the Sarcoma European-Latin American Network (SELNET) consortium participated, including countries in the Americas and Europe. The European Society for Medical Oncology-Magnitude of clinical benefit scale was applied to systemic-treatment recommendations to support prioritization.ResultsThere were 80 SRs, 35 Rs, and 10 NCs among the 125 recommendations issued and completed by 31 multidisciplinary sarcoma experts. The consensus was higher among the 75 higher-priority recommendations (85%, 12%, and 3% for SR, R, and NC, respectively) than in the 50 lower-priority recommendations (32%, 52%, and 16% for SR, R, and NC, respectively).ConclusionThe consensus on 115 of 125 recommendations indicates a high-level of convergence among experts. The SELNET consensus provides a tool for sarcoma multidisciplinary treatment committees during the COVID-19 outbreak.Implications for practiceThe Sarcoma European-Latin American Network (SELNET) consensus on sarcoma prioritization care during the COVID-19 era issued 125 pragmatical recommendations distributed as higher or lower priority to protect critical decisions on sarcoma care during the COVID-19 pandemic. A multidisciplinary team from 11 countries reached consensus on 115 recommendations. The consensus was lower among lower-priority recommendations, which shows reticence to postpone actions even in indolent tumors. The European Society for Medical Oncology-Magnitude of Clinical Benefit scale was applied as support for prioritizing systemic treatment. Consensus on 115 of 125 recommendations indicates a high level of convergence among experts. The SELNET consensus provides a practice tool for guidance in the decisions of sarcoma multidisciplinary treatment committees during the COVID-19 outbreak.

Dataset Information

Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.

Objective

Methods

Results

Conclusion

Publications

Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets